CEROS PHARMACEUTICALS
Ceros Pharmaceuticals Inc., a Cambridge, UK-based developer of compounds to treat osteoporosis.
CEROS PHARMACEUTICALS
Industry:
Biotechnology Health Care Pharmaceutical
Address:
Cambridge, Cambridgeshire, United Kingdom
Country:
United Kingdom
Status:
Active
Similar Organizations
Fairhaven Pharmaceuticals
Fairhaven Pharmaceuticals is a developer of oral therapeutics intended to treat severe inflammatory conditions.
More informations about "Ceros Pharmaceuticals"
Ceros Pharmaceuticals - Drug pipelines, Patents, Clinical trials
Explore Ceros Pharmaceuticals with its drug pipeline, therapeutic area, technology platform, 2 news. Explore Ceros Pharmaceuticals with its drug pipeline, therapeutic area, technology …See details»
Ceros Pharmaceuticals, Inc. - VentureRadar
Avidas Pharmaceuticals USA n/a n/a. Protein Polymer Technologies Inc. (PPTI) USA n/a n/a. Ardena Belgium n/a Ardena is a fully integrated Contract Development & Manufacturing …See details»
Ceros Management and Advisory - LinkedIn
Ceros Management and Advisory | 24 followers on LinkedIn. Supporting the development of people and products to improve life | Winner: 2024 Canadian Business Awards – Best Clinical Research ...See details»
Ceros Pharmaceuticals - Crunchbase
Ceros Pharmaceuticals Inc., a Cambridge, UK-based developer of compounds to treat osteoporosis.See details»
Ceros Pharmaceuticals acquired by Auxeris Therapeutics
Jan 16, 2004 Ceros Pharmaceuticals Ceros Pharmaceuticals Inc., a Cambridge, UK-based developer of compounds to treat osteoporosis. Acquiring Organization: Auxeris Therapeutics …See details»
Ceros Pharmaceuticals Inc Company Profile, Financial and
DigitGaps report on Ceros Pharmaceuticals Inc delivers a detailed in-depth and comprehensive insights of the company, its history, corporate strategy, its businesses and structures, and …See details»
Ceros Management | Clinical Research Consulting
Winner: 2023 GHP Magazine Healthcare and Pharmaceutical Awards – Best Clinical Business Operations Consultancy. Ceros Management and Advisory, Ltd. [email protected] (US) +1 …See details»
Ceros Pharmaceuticals, Inc. (United Kingdom) (Ceros …
了解Ceros Pharmaceuticals, Inc. (United Kingdom) (Ceros Pharmaceuticals, Inc. (United Kingdom))公司的药物管线，治疗领域，技术平台，以及它的。See details»
Ceros Pharmaceuticals-动脉网 - vbdata.cn
Ceros Pharmaceuticals，Inc。是一家生物技术公司，专注于化合物治疗骨质疏松症的开发。See details»
Ceros Pharmaceuticals: 药物管线，专利，临床试验 - 智慧芽新药情 …
了解Ceros Pharmaceuticals公司的药物管线，治疗领域，技术平台，以及它的1篇新闻。See details»
Top 20 CROs: A Comprehensive Guide to the Top 20 Contract …
The pharmaceutical industry has always relied on the expertise of Contract Research Organizations (CROs) to navigate the complexities of drug development. These organizations …See details»
Saving a Pharmaceutical $5 Million by Reducing Transaction …
Saving a Pharmaceutical $5 Million by Reducing Transaction Timeline. ... The organization paused the development of a lifesaving therapy during phase II clinical trials when it …See details»
Contract Research Organizations: Key Partners In The Drug
Apr 9, 2021 Pharmaceutical companies outsource their clinical research capabilities to contract research organizations (CROs) for a number of reasons, including therapeutic expertise of the …See details»
Indonesia Interview Series - Ceros
Leader from Konimex. Leader from Kalbe Farma. Click each section to watch the interview series. Dr. Jeffrey Spaeder, M.D. Chief Scientific and Medical Officer, IQVIA. NEXT. OrganiSee details»
Auxeris Therapeutics - Funding, Financials, Valuation & Investors
Auxeris Therapeutics has acquired Ceros Pharmaceuticals on Jan 16, 2004. Which types of acquisition does this organization make most frequently? Show . Acquiree Name . Announced …See details»
Keros Therapeutics Announces Global License Agreement with …
Dec 3, 2024 Keros Therapeutics to receive upfront payment of $200 million and is eligible to receive development, approval and commercial milestone payments with the potential to …See details»
The Role of CROs in Generic Drug Development
Aug 21, 2024 How to Find a Reputable Active Pharmaceutical… China and Potential Opportunity for Pharmaceutical… When should you outsource drug development; CDCDB: A …See details»
Naxicap Partners acquires Ceres Pharma - Alychlo
Jul 12, 2021 Naxicap Partners reached an agreement with Alychlo NV and Mario Debel (co-founder and CEO) to acquire 100% of the shares of Ceres Pharma NV. Simultaneously Mr. …See details»
Centers of Excellence in Pharma: Driving Efficiency and Innovation
2 days ago In today’s fast-paced pharmaceutical industry, Centers of Excellence (CoEs) have become vital for companies aiming to meet the diverse and evolving business needs of …See details»
Ceres Pharma acquires Labophar - Dovesco
Ceres Pharma is a dynamic and fast growing, Belgian based, pharmaceutical company, founded in 2017 by CEO Mario Debel and Alychlo and recently acquired in 2021 by Naxicap Partners. …See details»